BRUKER CORPORATION Inventory, Finished Goods, Net of Reserves
BRUKER CORPORATION (BRKR) had Inventory, Finished Goods, Net of Reserves of $231.30 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-05
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $231.30M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $234.30M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $243.10M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $269.00M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $231.30M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $234.30M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $243.10M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $269.00M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $273.20M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $251.10M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $228.50M 10-K · filed 2026-02-27 |
| 2024-09-30 | $273.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $265.60M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $204.20M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $183.90M 10-K · filed 2025-03-03 |
| 2023-09-30 | $160.60M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $154.50M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $133.10M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $128.20M 10-K · filed 2024-02-29 |
| 2022-09-30 | $129.20M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $140.20M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $145.30M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $144.90M 10-K · filed 2023-03-01 |
| 2021-09-30 | $155.90M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $161.70M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $157.00M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $152.10M 10-K · filed 2022-02-28 |
| 2020-09-30 | $139.10M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $131.30M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $115.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $104.50M 10-K · filed 2021-03-01 |
| 2019-09-30 | $101.80M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $105.60M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $92.30M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $94.80M 10-K · filed 2020-03-27 |
| 2018-09-30 | $89.50M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $87.70M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $95.00M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $96.60M 10-K · filed 2019-03-01 |
| 2017-09-30 | $108.40M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $105.90M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $104.70M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $91.80M 10-K · filed 2018-03-16 |
| 2016-09-30 | $99.10M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $95.00M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $91.30M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $93.30M 10-K · filed 2017-03-01 |
| 2015-09-30 | $119.60M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $113.30M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $134.00M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $109.90M 10-K · filed 2016-02-29 |
| 2014-09-30 | $149.20M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $158.20M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $170.00M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $155.30M 10-K · filed 2015-02-27 |
| 2013-09-30 | $162.60M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $148.00M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $166.60M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $160.50M 10-K · filed 2014-02-27 |
| 2012-09-30 | $175.80M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $170.90M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $183.90M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $175.30M 10-K · filed 2013-02-28 |
| 2011-09-30 | $175.20M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $174.90M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $143.90M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |